Clinical Trials Browser

Phase 2 × Suspended × Nivolumab × Clear all

NCT07011550 2026-03-11

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Phase 2 Suspended

Gastrointestinal

Microsatellite-stable Colorectal Cancer

NCT05928806 2026-02-11

ARCITECT

Phase 2 Suspended

Advanced Renal Cell Carcinoma

NCT05445609 2025-09-19

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 2 Suspended

Prostatic Neoplasms